Table 2.
Lipid profile and biomarkers in the group with HIV and the control group without HIV
| Characteristics | Group with HIV
(Total=60) |
Group without
HIV (Total=30) |
P-value |
|---|---|---|---|
| Median fasting plasma glucose (mg/dL, IQR) | 94 (87–106.5) | 89 (82–99) | 0.043 |
| Median total cholesterol (mg/dL, IQR) | 211.5 (191.5–106.5) | 203.5 (168–222) | 0.070 |
| Median triglycerides (mg/dL, IQR) | 145 (111–205) | 100 (70–153) | 0.002 |
| Median LDL (mg/dL, IQR) | 134.2 (113.8–155.9) | 130 (102–148) | 0.210 |
| Median HDL (mg/dL, IQR) | 44 (37.5–54) | 48.5 (41–55) | 0.438 |
| Impaired fasting glucose (mg/dL, IQR) (FPG>100) (n) | 19 (31.7%) | 7 (23.3%) | 0.414 |
| Hypercholesterolemia (total cholesterol >200 mg/dL) (n) | 38 (63.3%) | 15 (50%) | 0.226 |
| Hypertriglyceridemia (triglycerides >150 mg/dL) (n) | 29 (48.3%) | 8 (26.7%) | 0.049 |
| High LDL (LDL >130 mg/dL) (n) | 34 (56.7%) | 15 (50%) | 0.549 |
| Low HDL (HDL <40 mg/dL) (n) | 17 (28.3%) | 7 (23.3%) | 0.613 |
| Hs-CRP (g/dL, IQR) | 1.59 (0.66–4) | 1.46 (0.74–2.17) | 0.325 |
| Hs-CRP >5.0 g/dL (n) | 11 (18.3%) | 3 (10%) | 0.304 |
BMI: body mass index; LDL: low density lipoprotein cholesterol; HDL: high density lipoprotein cholesterol; hs-CRP: high-sensitivity C-reactive protein; VL: viral load; FPG: fasting plasma glucose